Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model.

Authors :: Molica S
Giannarelli D
Visentin A
Reda G
Sportoletti P
Frustaci AM
Chiarenza A
Ciolli S
Vitale C
Laurenti L
De Paoli L
Murru R
Gentile M
Moia R
Rigolin GM
Levato L
Giordano A
Del Poeta G
Stelitano C
Deodato M
Ielo C
Noto A
Guarente V
Coscia M
Tedeschi A
Gaidano G
Cuneo A
Foa' R
Trentin L
Mauro FR
Source :: American journal of hematology [Am J Hematol] 2022 May; Vol. 97 (5), pp. E176-E180. Date of Electronic Publication: 2022 Feb 25.
Publication Year :: 2022

Subjects :: Adenine analogs & derivatives
Humans
Piperidines
Prognosis
Protein Kinase Inhibitors adverse effects
Leukemia, Lymphocytic, Chronic, B-Cell drug therapy

Full Text Access

Tools